Literature DB >> 22939545

"And mostly they have a need for sleeping pills": physicians' views on treatment of sleep disorders with drugs in nursing homes.

Uwe Flick1, Vjenka Garms-Homolová, Gundula Röhnsch.   

Abstract

The percentage of nursing home residents treated with hypnotic medications is high, as many authors report, despite the fact that such medications are almost always associated with undesirable effects for old people. This article takes a closer look at nursing home physicians' views of prescriptions when treating sleep disorders of nursing home residents. How do physicians characterize the treatment strategy for residents suffering from sleep disorders? How do they balance the benefits and risks of the hypnotic medication? Under what circumstances do they accept negative consequences? To answer these questions, N=20 physicians (aged 36 to 68 years) in 16 nursing homes in a German city were interviewed. The physicians were either employed by nursing homes or worked on a contract basis. Comparative categorization of the data produced a typology across cases. Three interpretative patterns concerning the use of drugs for treating sleep disorders were identified--"by request," "ambivalence," and "reflected prescription." Differences between them were determined by the significance of residents' wishes, neglect of risks, particularly that of addiction, and the attempt to balance benefits and disadvantages. The study showed deficits in professional management of sleep disorders in nursing homes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22939545     DOI: 10.1016/j.jaging.2012.07.001

Source DB:  PubMed          Journal:  J Aging Stud        ISSN: 0890-4065


  8 in total

Review 1.  Relationship between Organizational Culture and the Use of Psychotropic Medicines in Nursing Homes: A Systematic Integrative Review.

Authors:  Mouna Sawan; Yun-Hee Jeon; Timothy F Chen
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

2.  Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.

Authors:  Carina Lundby; Trine Graabaek; Jesper Ryg; Jens Søndergaard; Anton Pottegård; Dorthe Susanne Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-02-27       Impact factor: 4.335

3.  'We can do only what we have the means for' general practitioners' views of primary care for older people with complex health problems.

Authors:  Anna Herzog; Beate Gaertner; Christa Scheidt-Nave; Martin Holzhausen
Journal:  BMC Fam Pract       Date:  2015-03-14       Impact factor: 2.497

4.  What factors are important for deprescribing in Australian long-term care facilities? Perspectives of residents and health professionals.

Authors:  Justin P Turner; Susan Edwards; Melinda Stanners; Sepehr Shakib; J Simon Bell
Journal:  BMJ Open       Date:  2016-03-10       Impact factor: 2.692

5.  General practitioners' views on (long-term) prescription and use of problematic and potentially inappropriate medication for oldest-old patients-A qualitative interview study with GPs (CIM-TRIAD study).

Authors:  Nadine Janis Pohontsch; Kathrin Heser; Antje Löffler; Britta Haenisch; Debora Parker; Tobias Luck; Steffi G Riedel-Heller; Wolfgang Maier; Frank Jessen; Martin Scherer
Journal:  BMC Fam Pract       Date:  2017-02-17       Impact factor: 2.497

6.  General practitioners' concepts on issuing out-of-pocket prescriptions for hypnotics and sedatives in Germany.

Authors:  Katharina Schmalstieg-Bahr; Christiane A Müller; Eva Hummers
Journal:  Fam Pract       Date:  2019-11-18       Impact factor: 2.267

7.  Stakeholders' views on the use of psychotropic medication in older people: a systematic review.

Authors:  Eliza Bednarczyk; Sarah Cook; Ruth Brauer; Sara Garfield
Journal:  Age Ageing       Date:  2022-03-01       Impact factor: 10.668

Review 8.  Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis.

Authors:  Kristen Anderson; Danielle Stowasser; Christopher Freeman; Ian Scott
Journal:  BMJ Open       Date:  2014-12-08       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.